A Study on Suicidality, Psychosis or Substance Abuse With Methylphenidate, Atomoxetine, Amphetamine/Dextroamphetamine or Lisdexamfetamine

CompletedOBSERVATIONAL
Enrollment

430,000

Participants

Timeline

Start Date

October 9, 2019

Primary Completion Date

October 25, 2019

Study Completion Date

October 25, 2019

Conditions
Attention Deficit Disorder With Hyperactivity
Interventions
DRUG

Methylphenidate

Methylphenidate is common ADHD medications in the United States. This is a non-interventional study and no drug will be given as part of this study. Analysis will be performed from data taken from three United States (US) health care databases and one US electronic health record database.

DRUG

Lisdexamfetamine

Lisdexamfetamine is common ADHD medications in the United States. This is a non-interventional study and no drug will be given as part of this study. Analysis will be performed from data taken from three US health care databases and one US electronic health record database.

DRUG

Atomoxetine

Atomoxetine is common ADHD medications in the United States. This is a non-interventional study and no drug will be given as part of this study. Analysis will be performed from data taken from on three US health care databases and one US electronic health record database.

DRUG

Amphetamine

Amphetamine is common ADHD medications in the United States. This is a non-interventional study and no drug will be given as part of this study. Analysis will be performed from data taken from on three US health care databases and one US electronic health record database.

DRUG

Dextroamphetamine

Dextroamphetamine is common ADHD medications in the United States. This is a non-interventional study and no drug will be given as part of this study. Analysis will be performed from data taken from on three US health care databases and one US electronic health record database.

Trial Locations (1)

08560

Janssen Investigative Site, Titusville

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT04132557 - A Study on Suicidality, Psychosis or Substance Abuse With Methylphenidate, Atomoxetine, Amphetamine/Dextroamphetamine or Lisdexamfetamine | Biotech Hunter | Biotech Hunter